LongGNSAug 2026
Genus plc
GreenWood identifies Genus's PRP gene-edit program as a potentially game-changing catalyst for the company. The fund believes the market is under-weighting the timing and…
GNS
1 published idea on Genus plc across 1 fund — 1 long and 0 short.
Each stock pitch below comes from a fund manager's own investor letter, not a 13F filing, so it carries the reasoning behind the portfolio position on Genus: the full investment thesis, the risks the manager flagged, the conviction level and the time horizon. Positions may have changed since the letter was written.
GreenWood identifies Genus's PRP gene-edit program as a potentially game-changing catalyst for the company. The fund believes the market is under-weighting the timing and…